The DOI matches its Crossref record; 74 of the 75 references it cites were found in a registry or an index.
Astrocytic LRP1 Mediates Brain Aβ Clearance and Impacts Amyloid Deposition
Open accessAbstract
Accumulation and deposition of amyloid-β (Aβ) in the brain represent an early and perhaps necessary step in the pathogenesis of Alzheimer's disease (AD). Aβ accumulation leads to the formation of Aβ aggregates, which may directly and indirectly lead to eventual neurodegeneration. While Aβ production is accelerated in many familial forms of early-onset AD, increasing evidence indicates that impaired clearance of Aβ is more evident in late-onset AD. To uncover the mechanisms underlying impaired Aβ clearance in AD, we examined the role of low-density lipoprotein receptor-related protein 1 (LRP1) in astrocytes. Although LRP1 has been shown to play critical roles in brain Aβ metabolism in neurons and vascular mural cells, its role in astrocytes, the most abundant cell type in the brain responsible for maintaining neuronal homeostasis, remains unclear. Here, we show that astrocytic LRP1 plays a critical role in brain Aβ clearance. LRP1 knockdown in primary astrocytes resulted in decreased cellular Aβ uptake and degradation. In addition, silencing of LRP1 in astrocytes led to downregulation of several major Aβ-degrading enzymes, including matrix metalloproteases MMP2, MMP9, and insulin-degrading enzyme. More important, conditional knock-out of the Lrp1 gene in astrocytes in the background of APP/PS1 mice impaired brain Aβ clearance, exacerbated Aβ accumulation, and accelerated amyloid plaque deposition without affecting its production. Together, our results demonstrate that astrocytic LRP1 plays an important role in Aβ metabolism and that restoring LRP1 expression and function in the brain could be an effective strategy to facilitate Aβ clearance and counter amyloid pathology in AD. SIGNIFICANCE STATEMENT Astrocytes represent a major cell type regulating brain homeostasis; however, their roles in brain clearance of amyloid-β (Aβ) and underlying mechanism are not clear. In this study, we used both cellular models and conditional knock-out mouse models to address the role of a critical Aβ receptor, the low-density lipoprotein receptor-related protein 1 (LRP1) in astrocytes. We found that LRP1 in astrocytes plays a critical role in brain Aβ clearance by modulating several Aβ-degrading enzymes and cellular degradation pathways. Our results establish a critical role of astrocytic LRP1 in brain Aβ clearance and shed light on specific Aβ clearance pathways that may help to establish new targets for AD prevention and therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This family of receptors have essential roles in lipid and cholesterol transport, with LRP1 also implicated in the astrocytic uptake and degradation of amyloid-β [106-108].”
From Global identification of neuronal and astrocytic integral membrane proteins that require Retromer for their endosomal recycling (2026) · cites this paper as [107]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“which has been implicated in the uptake and degradation of amyloid-β and tau [107, 147].”
From Global identification of neuronal and astrocytic integral membrane proteins that require Retromer for their endosomal recycling (2026) · cites this paper as [107]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Clearance of Aβ through direct association with ApoE or through binding to ApoE receptors decreases amyloid pathology in mouse models.”
From ApoE lipoproteins in the central nervous system under homeostasis and role in Alzheimer’s disease and related disorders (2026) · cites this paper as [87]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, LDLR, LRP1 and ApoER2 receptors are also present in astrocytes [15,24,63] and have been also shown to be involved in the Aβ clearance mediated by astrocytes [50,64].”
From ApoE3 vs. ApoE4 Astrocytes: A Detailed Analysis Provides New Insights into Differences in Cholesterol Homeostasis (2022) · cites this paper as [64]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Furthermore, receptors that bind to apoE have been shown to influence amyloid pathology. 21 , 41”
From Deletion of miR-33, a regulator of the ABCA1–APOE pathway, ameliorates neuropathological phenotypes in APP/PS1 mice (2024) · cites this paper as [41]
The cited source says what the claim attributes to it.
In the citing paper
“has also been implicated in AD pathology. 21 , 32 , 33”
The cited source says what the claim attributes to it.
In the citing paper
“LRP1 is a widely expressed receptor that was previously shown to enhance Aβ uptake, clearance, and degradation. 21”
The cited source says what the claim attributes to it.
In the citing paper
“Similarly, knockout of LRP1 in astrocytes decreases Aβ clearance and increases Aβ pathology [85, 87].”
From ApoE lipoproteins in the central nervous system under homeostasis and role in Alzheimer’s disease and related disorders (2026) · cites this paper as [87]
The cited source says what the claim attributes to it.
In the citing paper
“astrocytic LDLR and LRP1 have been shown to be involved in Aβ uptake and clearance, as confirmed by the significant change in Aβ accumulation observed in experimental models characterized by the knockdown or the overexpression of one of these two receptors [50,64,76]”
From ApoE3 vs. ApoE4 Astrocytes: A Detailed Analysis Provides New Insights into Differences in Cholesterol Homeostasis (2022) · cites this paper as [64]
The cited source says what the claim attributes to it.
In the citing paper
“Cellular receptors such as low-density lipoprotein receptor-related protein 1 (LRP1) [47–50], LRP8 [51], LDLR [52] or RAGE [53] may also affect APP metabolism by either modulating the activities of β- and γ-secretase and/or directly Aβ levels through endocytosis.”
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Interestingly, Apoe-deficient astrocytes upregulate genes associated with inhibition of Aβ fibrillization (Ptgds and Cst3) and regulation of protein degradation (Ubb, Ubc and Ctsl) (Apelt et al, 2003; Davis et al, 2021; Liu et al, 2017a; Wegiel et al, 2000).”
From APOE from astrocytes restores Alzheimer’s Aβ-pathology and DAM-like responses in APOE deficient microglia (2024) · cites this paper as Liu et al, 2017a
Experimental — accuracy not yet measuredIn the citing paper
“AD is accompanied by activation of microglia and astrocytes1,2 that affects the clearance and production of Aβ42,3,4 development and propagation of tau pathology,5 exacerbates neurodegeneration, and influences disease progression and severity.6,7”
From CSF biomarkers of neuroinflammation and cerebrovascular dysfunction in early Alzheimer disease (2018) · cites this paper as [4]
In the citing paper
“the low‐density lipoprotein receptor‐related protein 1 (LRP1) plays an important role in Aβ degradation and transport across the blood–brain barrier (Kanekiyo et al., 2011, 2013; Liu et al., 2017; Ma et al., 2018; Shibata et al., 2000; Storck et al., 2016)”
From Alzheimer's amyloid‐β and tau protein accumulation is associated with decreased expression of the LDL receptor‐associated protein in human brain tissue (2020) · cites this paper as Liu et al., 2017
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Astrocytes: Biology and pathology
Sofroniew, M. V., & Vinters, H. V. (2010) · Acta Neuropathologica · doi:10.1007/s00401-009-0619-8 · Cited by 5,196
2016 Alzheimer's disease facts and figures
Alzheimer's Association (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.03.001 · Cited by 5,069
Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy
Liu, C.-C., Kanekiyo, T., Xu, H., & Bu, G. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.263 · Cited by 3,459
Self-citationBlennow, K., de Leon, M. J., & Zetterberg, H. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69113-7 · Cited by 3,134
Neurovascular pathways to neurodegeneration in Alzheimer’s disease and other disorders
Zlokovic, B. V. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3114 · Cited by 2,969
Decreased Clearance of CNS β-Amyloid in Alzheimer’s Disease
Mawuenyega, K. G., Sigurdson, W., Ovod, V., Munsell, L., Kasten, T., Morris, J. C., Yarasheski, K. E., & Bateman, R. J. (2010) · Science · doi:10.1126/science.1197623 · Cited by 2,078
2015 Alzheimer's disease facts and figures
Alzheimer's Association (2015) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2015.02.003 · Cited by 1,684
Lentivirus-delivered stable gene silencing by RNAi in primary cells.
Stewart, S. A., Dykxhoorn, D. M., Palliser, D., Mizuno, H., Yu, E. Y., An, D., Sabatini, D., Chen, I. S. Y., Hahn, W., Sharp, P., et al. (2003) · RNA: A publication of the RNA Society · doi:10.1261/rna.2192803 · Cited by 1,619
Cited by
Sorted by citations
Items 201–270 of 270
Molecular heterogeneity of the non-human primate cochlea
Chen, X., Che, Y., Qi, J., Cen, M., Gao, S., Zhu, B., Ao, Y., Ma, X., Cheng, C., Guo, R., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-68350-2 · Cited by 4
A receptor that lets dementia-associated tau proteins into neurons
Deinhardt, K. (2020) · Nature · doi:10.1038/d41586-020-00874-z · Cited by 4
Cavieres-Lepe, J., & Stuardo, N. (2021) · Journal of Neuroscience · doi:10.1523/jneurosci.2352-20.2021 · Cited by 4
Sex differences in CSF biomarkers of Alzheimer’s disease
Mielke, M. M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819344-0.00012-0 · Cited by 4
Noel, R. L., Kline-Schoder, A. R., Batts, A. J., Kwon, N., Tsitsos, F., & Konofagou, E. E. (2025) · iScience · doi:10.1016/j.isci.2025.113173 · Cited by 3
Astrocyte Autophagy in Neurodegenerative Diseases: Current Progress in Mechanisms and Therapeutics
Qian, J., Ren, S., Ren, T., Shi, R., Qiao, L., & Kang, J. (2025) · Neurochemical Research · doi:10.1007/s11064-025-04532-6 · Cited by 3
Wei, H., Zhang, G., Xu, Y., Zhao, A., Zheng, Y., Shao, Y. W., Yang, L., Wang, J., & Jiang, X. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.157238 · Cited by 3
Self-citationAmyloid-β clearance: an astrocytic perspective
Li, J., Lv, Z., Chen, X. P., Fu, F., Yang, K., Lai, G., Wu, H., & Xie, G. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2026.1812081 · Cited by 3
Xiang, M., Cao, S.-Y., Sun, X.-H., Hu, J.-W., Lv, M., Li, J., & Li, W. (2026) · Translational Neurodegeneration · doi:10.1186/s40035-026-00573-1 · Cited by 3
Self-citationBridging prion biology and Alzheimer’s disease: from pathogenic seeds to precision therapeutics
Wang, W., Feng, Z., Shu, L., Hu, Y., Chen, Y., Zhang, B., & Huang, H. (2025) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2025.1660151 · Cited by 3
Aarnio, M., Zhao, P., Yu, S., Christian, C. J., Flanagan‐Steet, H. R., Wells, L., & Steet, R. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.790139 · Cited by 3
BMAL1 in Astrocytes: A Protective Role in Alzheimer’s and Parkinson’s Disease
Brash-Arias, D., García, L. I., Aranda-Abreu, G. E., Toledo‐Cárdenas, M. R., Pérez-Estudillo, C. A., & Chi-Castañeda, D. (2025) · Neuroglia · doi:10.3390/neuroglia6010001 · Cited by 2
Rozeboom, A., Broekaart, D. W. M., Anink, J. J., Boonkamp, L., Idema, S., Teunissen, C. E., Aronica, E., Gorter, J. A., & van Vliet, E. A. (2025) · Experimental Neurology · doi:10.1016/j.expneurol.2025.115149 · Cited by 2
Yang, S.-A., Park, S.-H., Kim, E.-H., Bae, W.-B., & Jhee, K.-H. (2025) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.2412.12026 · Cited by 2
Mechanistic Role of Astrocytic Rac1 Protein in Alzheimer's Disease
Jiang, F., Wang, N., & Meng, Q. (2025) · Aging and Disease · doi:10.14336/ad.2025.0502 · Cited by 2
Self-citationSialylation patterns in cerebral amyloid angiopathy
Fastenau, C., Crisp, R., Keating, M., Ochoa, E., Richardson, T. E., Flanagan, M. E., Walker, J. M., Hopp, S. C., & Bieniek, K. F. (2025) · Brain Pathology · doi:10.1111/bpa.70042 · Cited by 2
Modulating LRP1 Pathways in Alzheimer’s Disease: Mechanistic Insights and Emerging Therapies
Mushtaq, T., Hameed, H., Khan, M. A., Tariq, U., Hameed, A., & Zaman, M. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-05775-2 · Cited by 2
Ahamed, M. A., Guo, B., Khalid, M. A. U., Pal, T., Guo, F., & Guan, W. (2026) · Nano Today · doi:10.1016/j.nantod.2026.103033 · Cited by 2
Quach, B., Salehi, S. N., Roufegarinejad, R., Guleria, V. S., Mante, M., Florio, J. B., Rissman, R. A., & Winston, C. N. (2026) · Experimental Neurology · doi:10.1016/j.expneurol.2026.115893 · Cited by 2
Gong, M., Lan, J. X., & Miao, J. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1908574 · Cited by 3
Nurmakova, K., Gomes, G.-N. W., & Levine, Z. A. (2026) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2026.113494 · Cited by 2
Identification of TMED10 as A Regulator for Neuronal Exocytosis of Amyloid Beta 42
Meng, P., Sha, L., Yu, X., Wang, Y., Zhang, E., Meng, K., Li, B., Zhao, Q., & Xu, Q. (2025) · Neuroscience Bulletin · doi:10.1007/s12264-025-01492-3 · Cited by 2
Role of caspases, apoptosis and additional factors in pathology of Alzheimer's disease
Gupta, A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820122-0.00001-7 · Cited by 2
Commentary: LRP1 Is a Master Regulator of Tau Uptake and Spread
Fearon, C., & Lynch, T. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.557509 · Cited by 2
Single-cell Data Unveil the Multifaceted Role of LRP1 in Alzheimer’s Disease PathogenesisPreprint
Chen, K., Wei, Z., Wei, A., Qin, Y., Liu, C., Xin, H., Chen, S., Ge, Y., Li, B., Wang, K., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-3827465/v1 · Cited by 3
Self-citationScavenger receptors: key players in the immunological puzzle of lupus
Hahn, S., Chitre, M., Shepard, D., Rashid, R., & Ramirez‐Ortiz, Z. G. (2025) · Frontiers in Lupus · doi:10.3389/flupu.2025.1679564 · Cited by 1
Arzola, E. P., Yu, G., Xiong, L., Lee, D., Wu, A., Paruchuri, S., Skinner, J., Wang, M., Zhang, B., Mei, L., et al. (2025) · Glia · doi:10.1002/glia.70114 · Cited by 1
Xu, L., Song, Y., Tao, H., Ni, L., Huang, H., & Shen, J. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.115112 · Cited by 1
Gene Therapy for Neurological Disorders
Malviya, R., Singh, A. K., Goyal, P., & Sundram, S. (2024) · Apple Academic Press eBooks · doi:10.1201/9781003494102 · Cited by 1
Guo, H., Peng, X., Zhang, X. C., Ruganzu, J. B., Wu, X., Zhao, M., Pengbo, Y., Ji, S., & Yang, W. (2026) · Experimental Cell Research · doi:10.1016/j.yexcr.2026.114920 · Cited by 1
Gupta, A., Thirugnanam, K., Bice, Z., Lowman, A. K., Rarick, K. R., LaViolette, P. S., Pan, A., Franczak, M. B., & Ramchandran, R. (2026) · BMC Molecular and Cell Biology · doi:10.1186/s12860-026-00581-z · Cited by 1
Parnova, R. G., & Fock, E. M. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27062835 · Cited by 1
Soluble epoxide hydrolase drives neurovascular dysfunction in a model of amyloidosis
DeMeglio, M., Biasi, E. S. D., Breunig, P., Candlish, M., Sauerland, C., Günther, S., Kawase, H., Peguera, B., Bohnstaedt, C., Herms, J. W., et al. (2026) · Brain · doi:10.1093/brain/awag184 · Cited by 1
Self-citationLi, E., Zhang, P., & Feng, W. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1783786 · Cited by 1
APP /Aβ Signaling Orchestrates Reactive Astrocyte Networks in Alzheimer's Disease
Jáuregui, G. V., Coomes, S., Emmett, E., Thatcher, A., Oyelakin, N., Čarná, M., Zelinková, J., Novotný, J., Polakova, N., Kuruvilla, T., et al. (2026) · Journal of Neurochemistry · doi:10.1111/jnc.70526 · Cited by 1
Is amyloid beta peptide a driver of inflammaging?
Kechko, O. I., Moskalev, A. A., Franceschi, C., Mitkevich, V. A., & Makarov, A. А. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103280 · Cited by 1
Evidence that glial cells attenuate G47R transthyretin accumulation in the central nervous system
Sumi‐Akamaru, H., Eto, M., Yamauchi, A., Uehara, T., Kakuda, K., Obayashi, K., Kato, S., Naka, T., & Mochizuki, H. (2017) · Neuropathology · doi:10.1111/neup.12412 · Cited by 1
Risen, S. J., Wahl, D., LaRocca, T. J., & Moreno, J. A. (2025) · Neuroglia · doi:10.3390/neuroglia6020022 · Cited by 1
Miao, J., Wang, J., Li, Y., Zhang, H., Zhang, Y., Li, Q., Xiao, B., Zhou, W., & Guo, J. (2026) · Advanced Science · doi:10.1002/advs.77929
Self-citationClearing the way to a healthy brain
Morris, J. K. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aan0767
Hettinger, J. C. (2017) · Open Scholarship Institutional Repository (Washington University in St. Louis) · doi:10.7936/k7jq10fn
Targeting Astrocytes With Viral Gene Therapy for Alzheimer’s Disease
Rosenthal, Z. P., Kraft, A. W., Czerniewski, L. R., & Lee, J. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809813-4.00005-3
Transcriptional and functional consequences of neuron-astrocyte interactions
Jiwaji, Z. (2019) · ERA
DIET INFLUENCES PERIPHERAL AMYLOID β METABOLISM: A ROLE FOR CIRCULATING INSULIN-LIKE GROWTH FACTOR IPreprint
Herrero-Labrador, R., Trueba-Sáiz, Á., Martinez‐Rachadell, L., de Sevilla, E. F., Díaz-Pacheco, S., Fernandez, A. F., & Aleman, I. T. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.07.09.180265
LRP1 is a negative regulator of oligodendrogenesis in the adult mouse central nervous system
Auderset, L. (2020) · UTAS Research Repository · doi:10.25959/100.00034806
Endocytosis in β-amyloid biology and Alzheimer’s disease
Heckmann, B. L., & Green, D. R. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-89906-2.00009-5
Mishra, R., Joykutty, L., & Oyarbide, K. (2019) · Journal of Emerging Investigators · doi:10.59720/19-018
Feng, W., Zhang, Y., Wang, Z., Xu, H., Wu, T., Marshall, C., Gao, J., & Xiao, M. (2020) · Figshare · doi:10.6084/m9.figshare.13047485
Analysis of transporter activity in an Alzheimer’s disease blood-brain barrier cell model
Chaves, J. (2024) · Queensland University of Technology · doi:10.5204/thesis.eprints.248279
Patel, B., & Acharya, N. S. (2024) · Journal of Young Pharmacists · doi:10.5530/jyp.2024.16.22
ApoE Receptors, Molecular Processes, and Cellular Signaling Pathways
Jaeschke, A., & Hui, D. Y. (2025) · Springer eBooks · doi:10.1007/978-3-031-52641-1_6-1
Lewandowska, J., Majewski, J., & Roszek, K. (2025) · Brain Sciences · doi:10.3390/brainsci15060570
Lavandula angustifolia and Cyperus rotundus Extract Treatments Ameliorate Copper Toxicity in Rats
Salari, M., Balooch, F. D., Fatemi, S. J., & Dogani, M. (2025) · Brain and Behavior · doi:10.1002/brb3.70624
Li, R., Xiong, W., & Sun, C. (2025) · International Journal of Neuroscience · doi:10.1080/00207454.2025.2540989
Unfriendly dialogue of gut microbiota and lipid metabolism in Alzheimer's disease
Cao, Y., Liu, S., Zhang, H., Pan, W., & Wang, D. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251391771 · Cited by 1
MEGF10 knockout promotes cortical and hippocampal amyloid deposition in AD mouse model
Fujita, Y., Yabe, T., Yamada, Y., Kiuchi, R., Nagase, M., Nakamori, R., Ichikawa, S., Obara, T., Yasuda, H., Kurano, J., et al. (2025) · Neuroscience Letters · doi:10.1016/j.neulet.2025.138487
Feng, W., Zhang, Y., Wang, Z., Xu, H., Wu, T., Marshall, C., Gao, J., & Xiao, M. (2020) · Figshare · doi:10.6084/m9.figshare.13047482
Boccalini, C., Hristovska, I., Peretti, D. E., Mendes, A. J., Scheffler, M., Frisoni, G. B., & Garibotto, V. (2026) · The EANM Journal · doi:10.1016/j.eanmj.2026.100217
Molecular mechanisms of action of MT-MMPs involved in the pathogenesis of Alzheimer’s disease
García‐González, L. (2020) · theses.fr (ABES) · doi:10.70675/a04672c0z1f4az472ezbcd5zbea446eac50c
Role of LSR in the regulation of cholesterol homeostasis in the central nervous system
Hajj, A. E. (2019) · theses.fr (ABES) · doi:10.70675/5772a646z01eez4001z9947z40d5d34bcfbb
Role of T-cell immunity in the pathophysiology of Alzheimer’s disease and other Tauopathies
Matta, K. (2024) · theses.fr (ABES) · doi:10.70675/cea4fe5ez67c3z4445z92f7z39af62ba059b
Shrinking of Extracellular Space During Metabolic Stress Accelerates Amyloid-β Aggregation
Oliveira, L. F. D., Karunarathne, K., Zona, D., Muschol, M., & Ullah, G. (2026) · Biomolecules · doi:10.3390/biom16071053
Ding, S., Guo, Z., Ji, H., & He, J. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1879368
Haq, N. U., Irshad, S. U., Bibi, Z., Rehman, S., Sohail, S., Irshad, S. R., Haider, N., Mir, S., Shareef, A., & Lucke-Wold, B. P. (2026) · Biomedicines · doi:10.3390/biomedicines14102314
Brain clearance of protein aggregates in degenerative diseases: the role of microglia and astrocytes
Xiong, M., Huang, Y., Jiang, H., & Zhang, Z. (2026) · Translational Neurodegeneration · doi:10.1186/s40035-026-00592-y
Strickland, M. R., & Holtzman, D. M. (2026) · Molecular Neurodegeneration · doi:10.1186/s13024-026-00970-0
Self-citationJones, E., Adams, H., Chen, K.-E., Maroof, F., Ibbotson, T. M., Nakamura, Y., Banks, P. J., Healy, M. D., Lewis, P. A., Heesom, K. J., et al. (2026) · doi:10.64898/2026.05.14.724903
Metadata
- Authors
- Liu, C.-C., Hu, J., Zhao, N., Wang, J., Wang, N., Cirrito, J. R., Kanekiyo, T., Holtzman, D. M., & Bu, G.
- Affiliations
- Mayo Clinic (US)
- Washington University in St. Louis (US)
- ORCID
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2017-03-08
- Volume
- 37
- Issue
- 15
- Pages
- 4023-4031
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC5391682
- OpenAlex
- W2593036876
- Cited by
- 267
- References
- 75
- Citations by year
- 2026: 23 · 2025: 39 · 2024: 27 · 2023: 32 · 2022: 29 · 2021: 32 · 2020: 36 · 2019: 26 · 2018: 13 · 2017: 10
- FWCI
- 17.39
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Digital Commons@Becker (Washington University School of Medicine) (submittedVersion)
- Rare & Special e-Zone (The Hong Kong University of Science and Technology) (submittedVersion)
- Funders
- American Heart Association (15SDG22460003)
- National Institutes of Health
- National Institute on Aging (RF1AG051504, R01AG027924, RF1AG046205, R01AG046205, R01AG035355, P50AG016574)
- National Institute of Neurological Disorders and Stroke (P01NS074969)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Clinical Neurology › Cerebrospinal fluid and hydrocephalus
- Keywords
- LRP1, astrocytes, amyloid-beta clearance, Alzheimer's disease, amyloid deposition, amyloid plaques, matrix metalloproteinases, insulin-degrading enzyme, APP/PS1 mice, conditional knockout
- MeSH terms
- Animals, Astrocytes, Brain, Cells, Cultured, Female, Humans, Male, Peptide Fragments, Receptors, LDL, Amyloid beta-Peptides, Mice, Knockout, Tumor Suppressor Proteins, Low Density Lipoprotein Receptor-Related Protein-1, Mice, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
